KRT1 is discovered as a novel biomarker in aggressive cancers for its overexpression in epithelial cell surface, and KRT1-targeted reagents could offer innovative therapy for cancer treatments and diagnosis [40]. The gene discussed is KRT1; the disease is cancer.